2024

1. Impact of prior antihypertensive treatment on COVID-19 outcomes, by active ingredient

   Inflammopharmacology, Vol. 32, Núm. 3, pp. 1805-1815

2. Outpatient Antipsychotic Use and Severe COVID-19: Avoiding the Impact of Age in a Real-World Data Study

   International Journal of Neuropsychopharmacology, Vol. 27, Núm. 4

3. Outpatient glucocorticoid use and COVID-19 outcomes: a population-based study

   Inflammopharmacology, Vol. 32, Núm. 4, pp. 2305-2315

4. The role of traditional NSAIDs and selective COX-2 inhibitors on COVID-19 outcomes: a real-world data study

   Inflammopharmacology, Vol. 32, Núm. 6, pp. 3697-3705